
Novartis' spending on research and development by segment 2017-2022
This statistic shows the expenditure on research and development of pharmaceutical company Novartis from 2017 to 2022, by business segment. In 2022, the company spent the highest amount within the given period, around 9.2 billion U.S. dollars, for research and development in the Innovative Medicines division.